Biotech highlights from ESMO 2020 including Gilead’s pursuit of Immunomedics, AMG 510’s viability in lung cancer, and encouraging results from the Autolus AUTO3 program.
Read More
Biotech highlights from ESMO 2020 including Gilead’s pursuit of Immunomedics, AMG 510’s viability in lung cancer, and encouraging results from the Autolus AUTO3 program.
Read More
Tags:
Categories:
Comments are closed